SciELO - Scientific Electronic Library Online

vol.9 número2Susceptibilidad a agentes antimicrobianos de cepas de Neisseria meningitidis aisladas en portadores índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados




  • No hay articulos citadosCitado por SciELO

Links relacionados

  • No hay articulos similaresSimilares en SciELO



versión impresa ISSN 1025-028Xversión On-line ISSN 1025-0298


INFANTE, Juan F et al. VA-DIFTET toxicity after repeated dosing in mice. Vaccimonitor [online]. 2000, vol.9, n.2, pp.1-6. ISSN 1025-028X.

Considering that the expected immunization schedule for man includes three doses of VA-DIFTET®, once demonstrated that this vaccine is safe for two animal species, the study of its toxicity by repeated dosing in mice was imperative, taking into account that in humans a three-dose schedule is used when the pertusis component is contraindicated. Two-hundred and ten OF1 mice of both sexes were used. Experimental groups were similar to those used in the single-dose toxicity study: duplex vaccine, diphtheria toxoid, tetanus toxoid, adjuvant, thiomersal, physiologic saline solution), and a non-treated control group. One group of male and another of female mice were randomly assigned to each treatment to receive 1, 2 or 3 intramuscular doses. Clinical symptoms, body weight increase, water and food intakes and the antibody titers (IgG by indirect ELISA) against the tetanus and diphtheria toxoids were evaluated after each administration. Finally, all mice were sacrificed and anatomopathological studies performed. The relative indexes of spleen and thymus and the spleen/thymus rate were also studied post-mortem. No evidence of toxicity was observed; however, those mice inoculated with the vaccine or the toxoids showed a significant immune response. Final results were considered satisfactory.

Palabras clave : Toxicity; VA-DIFTET®; repeated dosing; mouse.

        · resumen en Español     · texto en Español     · Español ( pdf )


Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons